文献速递颈动脉与弓上血管

代谢综合征对颈动脉内膜切除术后再狭窄发生的影响

The Effect of Metabolic Syndrome on the Occurrence of Restenosis After Carotid Endarterectomy.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2019-10-22

结果显示,MetS组与非MetS组在无再狭窄生存(HR 1.10;95%CI 0.98-1.23;p=.10)和全因死亡(HR 1.20;95%CI 0.94-1.54;p=.14)上均无显著差异。结论认为MetS不能预测CEA术后再狭窄,也不影响患者生存。

要点

  • MetS与CEA术后同侧再狭窄风险无显著关联(HR 1.10;95%CI 0.98-1.23;p=.10)。
  • MetS与CEA术后全因死亡风险无显著关联(HR 1.20;95%CI 0.94-1.54;p=.14)。
  • MetS不能作为CEA术后再狭窄的预测因素。

核心结论

  • 本研究表明MetS不能预测CEA术后再狭窄,且MetS的存在未对患者生存产生负面影响。

研究设计与样本

  • MetS定义为满足以下三项或以上:高血压、肥胖、高空腹血糖、高甘油三酯或低高密度脂蛋白胆固醇。
  • 主要结局为指数手术后同侧再狭窄,次要结局为随访期间全因死亡;采用链式方程多重插补处理缺失数据,并用Cox比例风险模型进行校正分析。

主要发现

  • MetS组与非MetS组无再狭窄生存率无显著差异(HR 1.10;95%CI 0.98-1.23;p=.10)。
  • MetS组与非MetS组全因死亡率无显著差异(HR 1.20;95%CI 0.94-1.54;p=.14)。
  • 263例患者因数据缺失无法确定MetS状态。

临床怎么用

  • 对于合并MetS的CEA患者,无需因MetS本身而额外担忧再狭窄或死亡风险增加。
  • MetS状态不应作为CEA术后强化监测再狭窄的唯一依据。

局限性

  • 263例患者因数据缺失无法确定MetS状态,可能影响结果。
  • 研究为回顾性设计,存在未测量混杂因素的可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The metabolic syndrome (MetS) is a cluster of risk factors for cardiovascular disease. The effect of MetS on clinical outcome in patients with cerebrovascular disease remains largely unknown because conflicting results have been published. This study aimed to determine the influence of MetS on the occurrence of restenosis after carotid endarterectomy (CEA). METHODS: All patients who underwent CEA between June 2003 and December 2014 in two tertiary academic referral centres in The Netherlands were included. MetS was defined if three or more of the following criteria were present: hypertension, obesity, high fasting serum blood glucose, high serum triglycerides, or low serum high density lipoprotein cholesterol. The primary outcome measure was the occurrence of ipsilateral restenosis after index surgery. The secondary outcome measure was (all cause) mortality during follow up. For the primary analysis, missing data were multiply imputed using multivariable imputation by chained equations. A Cox proportional hazards model was used to perform an adjusted analysis on the multiply imputed data sets. RESULTS: A total of 1668 CEA procedures (in 1577 patients) were performed. The presence or absence of MetS could not be determined in 263 patients because of missing data. There was no significant difference in freedom from restenosis in the MetS group vs. the no-MetS group (hazard ratio [HR], 1.10; 95% confidence interval [CI] 0.98-1.23; p = .10) or in all cause mortality (HR 1.20; 95% CI 0.94-1.54; p = .14). CONCLUSION: This study shows that MetS does not predict restenosis after CEA. Also, the presence of MetS did not influence patient survival negatively.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Wallis de Vries BM, Timmerman N, van Laarhoven CJHCM, et al. The Effect of Metabolic Syndrome on the Occurrence of Restenosis After Carotid Endarterectomy. Eur J Vasc Endovasc Surg. 2019. PMID: 31653610. doi:10.1016/j.ejvs.2019.06.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。